He W, Hong X, Chen G, Luo X, Lin Y
Front Med (Lausanne). 2024; 11:1314075.
PMID: 38343637
PMC: 10853395.
DOI: 10.3389/fmed.2024.1314075.
Hung C, Tsai T, Lee K, Hsu Y
Biomedicines. 2023; 11(4).
PMID: 37189614
PMC: 10135833.
DOI: 10.3390/biomedicines11040996.
Liu C, Kuang S, Wu L, Cheng Q, Gong X, Wu J
CNS Neurosci Ther. 2023; 29(7):1721-1737.
PMID: 37157237
PMC: 10324372.
DOI: 10.1111/cns.14225.
Luserna di Rora A, Jandoubi M, Martinelli G, Simonetti G
Molecules. 2023; 28(3).
PMID: 36770891
PMC: 9920029.
DOI: 10.3390/molecules28031224.
Ng L, Ma H, Poon R
J Biol Chem. 2023; 299(3):102957.
PMID: 36717077
PMC: 9986519.
DOI: 10.1016/j.jbc.2023.102957.
SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis.
Liu X, Zheng Y, Xiao M, Chen X, Zhu Y, Xu C
J Exp Clin Cancer Res. 2022; 41(1):353.
PMID: 36539837
PMC: 9764681.
DOI: 10.1186/s13046-022-02558-0.
A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma.
Deng K, Lin S, Xu Z, Qin J, Yuan L, Sun Y
Medicine (Baltimore). 2022; 101(41):e30982.
PMID: 36254009
PMC: 9575749.
DOI: 10.1097/MD.0000000000030982.
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.
Chiappa M, Petrella S, Damia G, Broggini M, Guffanti F, Ricci F
Front Oncol. 2022; 12:903016.
PMID: 35719948
PMC: 9201472.
DOI: 10.3389/fonc.2022.903016.
METTL3 promotes cell cycle progression via mA/YTHDF1-dependent regulation of translation.
Li H, Zhong Y, Cao G, Shi H, Liu Y, Li L
Int J Biol Sci. 2022; 18(8):3223-3236.
PMID: 35637959
PMC: 9134919.
DOI: 10.7150/ijbs.70335.
CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma.
Zhou C, Wang L, Hu W, Tang L, Zhang P, Gao Y
Bioengineered. 2022; 13(5):13089-13107.
PMID: 35615982
PMC: 9275923.
DOI: 10.1080/21655979.2022.2078940.
CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
Feng D, Lv J, Li K, Cao Q, Han J, Yu H
Cell Biol Toxicol. 2022; 39(5):1-18.
PMID: 35567596
DOI: 10.1007/s10565-022-09715-3.
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.
Wang X, Lu J, Li J, Liu Y, Guo G, Huang Q
J Transl Med. 2021; 19(1):396.
PMID: 34544426
PMC: 8454155.
DOI: 10.1186/s12967-021-03070-3.
USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B.
Antao A, Kaushal K, Das S, Singh V, Suresh B, Kim K
Int J Mol Sci. 2021; 22(16).
PMID: 34445214
PMC: 8395203.
DOI: 10.3390/ijms22168508.
In Silico Identification of Small Molecules as New Cdc25 Inhibitors through the Correlation between Chemosensitivity and Protein Expression Pattern.
Lauria A, Martorana A, La Monica G, Mannino S, Mannino G, Peri D
Int J Mol Sci. 2021; 22(7).
PMID: 33918281
PMC: 8038176.
DOI: 10.3390/ijms22073714.
Inhibition mechanism of naphthylphenylamine derivatives acting on the CDC25B dual phosphatase and analysis of the molecular processes involved in the high cytotoxicity exerted by one selected derivative in melanoma cells.
Aliotta F, Nasso R, Rullo R, Arcucci A, Avagliano A, Simonetti M
J Enzyme Inhib Med Chem. 2020; 35(1):1866-1878.
PMID: 32990107
PMC: 7580834.
DOI: 10.1080/14756366.2020.1819257.
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer.
Akkol E, Genc Y, Karpuz B, Sobarzo-Sanchez E, Capasso R
Cancers (Basel). 2020; 12(7).
PMID: 32707666
PMC: 7409047.
DOI: 10.3390/cancers12071959.
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review.
Liu K, Zheng M, Lu R, Du J, Zhao Q, Li Z
Cancer Cell Int. 2020; 20:213.
PMID: 32518522
PMC: 7268735.
DOI: 10.1186/s12935-020-01304-w.
Dephosphorylation of Plk1 occurs through PP2A-B55/ENSA/Greatwall pathway during mitotic DNA damage recovery.
Kim S, Hyun S, Jang Y
Cell Cycle. 2019; 18(10):1154-1167.
PMID: 31072185
PMC: 6592230.
DOI: 10.1080/15384101.2019.1617003.
Phosphatases in Mitosis: Roles and Regulation.
Moura M, Conde C
Biomolecules. 2019; 9(2).
PMID: 30736436
PMC: 6406801.
DOI: 10.3390/biom9020055.
Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
Qi D, Hu L, Jiao T, Zhang T, Tong X, Ye X
J Virol. 2018; 92(19).
PMID: 30021902
PMC: 6146813.
DOI: 10.1128/JVI.01118-18.